Immix Biopharma (IMMX) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Immix Biopharma (IMMX) Stock Forecast for 2024–2028. Sell or Buy?

Updated: June 23, 2024 (03:48)

Sector: Healthcare

The share price of Immix Biopharma, Inc. (IMMX) now

Latest session on the 21st of June for
Immix Biopharma, Inc. is positive
Trading Volume: 159032
Open: 1.87 /  High: 2.07 /  Low: 1.87
What analysts predict: $14
52-week High/Low: $7.75 / $1.55

50/200 Day Moving Average: $2.229 / $3.548

This figure corresponds to the Average Price over the previous 50/200 days. For Immix Biopharma stocks, the 50-day moving average is the resistance level today.

For Immix Biopharma stocks, the 200-day moving average is the resistance level today.

Are you interested in Immix Biopharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Immix Biopharma stock price in 2024, 2025, 2026, 2027, 2028. How much will one Immix Biopharma share be worth in 2024 - 2028?

When should I take profit in Immix Biopharma stock? When should I record a loss on Immix Biopharma stock? What are analysts' forecasts for Immix Biopharma stock? What is the future of Immix Biopharma stock? We forecast Immix Biopharma stock performance using neural networks based on historical data on Immix Biopharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Immix Biopharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Immix Biopharma shares. This happens once a day.


Historical and forecast chart of Immix Biopharma stock

The chart below shows the historical price of Immix Biopharma stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Immix Biopharma stock price can be found in the table below.

Long-term forecasts by years.

Immix Biopharma is a United States-based clinical stage biopharmaceutical company with a division in Australia (Immix Biopharma Australia).
Immix Biopharma conducts research in the treatment of cancer and inflammatory diseases. The company’s key experimental line, IMX-110, is in phase 1b / 2a clinical trials and is being investigated for efficacy in the treatment of solid tumors. Tests are taking place in the United States and Australia.

Immix Biopharma daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 25 2.15 2.09 2.18 4.44
Jun 26 2.18 2.10 2.21 5.48
Jun 27 2.22 2.11 2.31 9.20
Jun 28 2.25 2.20 2.31 4.71
Jun 29 2.21 2.14 2.26 5.44
Jun 30 2.20 2.10 2.29 8.85
Jul 01 2.24 2.16 2.28 5.74
Jul 02 2.24 2.14 2.34 9.56
Jul 03 2.20 2.11 2.27 7.25
Jul 04 2.13 2.07 2.18 5.68
Jul 05 2.18 2.14 2.25 5.40
Jul 06 2.29 2.20 2.36 7.22
Jul 07 2.38 2.27 2.49 9.82
Jul 08 2.46 2.37 2.58 8.73
Jul 09 2.45 2.41 2.51 4.39
Jul 10 2.55 2.49 2.61 4.62
Jul 11 2.66 2.56 2.73 6.42
Jul 12 2.68 2.56 2.76 7.74
Jul 13 2.69 2.65 2.74 3.41
Jul 14 2.63 2.57 2.68 4.23
Jul 15 2.62 2.54 2.66 4.89
Jul 16 2.56 2.51 2.64 5.02
Jul 17 2.55 2.49 2.65 6.65
Jul 18 2.52 2.47 2.56 3.86
Jul 19 2.63 2.55 2.74 7.67
Jul 20 2.58 2.53 2.67 5.45
Jul 21 2.49 2.45 2.59 5.56
Jul 22 2.48 2.44 2.56 5.06
Jul 23 2.49 2.41 2.56 6.26
Jul 24 2.53 2.42 2.63 8.53

Immix Biopharma Daily Price Targets


Immix Biopharma Stock Forecast 06-25-2024.

Forecast target price for 06-25-2024: $2.15.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 4.251%.
Pessimistic target level: 2.09
Optimistic target level: 2.18

Immix Biopharma Stock Forecast 06-26-2024.

Forecast target price for 06-26-2024: $2.18.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 5.192%.
Pessimistic target level: 2.10
Optimistic target level: 2.21

Immix Biopharma Stock Forecast 06-27-2024.

Forecast target price for 06-27-2024: $2.22.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 8.421%.
Pessimistic target level: 2.11
Optimistic target level: 2.31

Immix Biopharma Stock Forecast 06-28-2024.

Forecast target price for 06-28-2024: $2.25.
Positive dynamics for Immix Biopharma shares will prevail with possible volatility of 4.496%.
Pessimistic target level: 2.20
Optimistic target level: 2.31

Immix Biopharma Stock Forecast 06-29-2024.

Forecast target price for 06-29-2024: $2.21.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 5.156%.
Pessimistic target level: 2.14
Optimistic target level: 2.26

Immix Biopharma Stock Forecast 06-30-2024.

Forecast target price for 06-30-2024: $2.20.
Negative dynamics for Immix Biopharma shares will prevail with possible volatility of 8.128%.
Pessimistic target level: 2.10
Optimistic target level: 2.29

IMMX (IMMX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jul. 2.01 1.77 2.14 17.15
Aug. 2.04 1.93 2.34 17.27
Sep. 1.93 1.80 2.22 18.94
Oct. 1.90 1.80 2.22 18.88
Nov. 1.85 1.59 1.96 18.68
Dec. 1.90 1.63 2.08 21.49

Immix Biopharma forecast for this year


Immix Biopharma Stock Prediction for Jul 2024

An downtrend is forecast for this month with an optimal target price of $2.01001. Pessimistic: $1.77. Optimistic: $2.14


Immix Biopharma Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $2.04378. Pessimistic: $1.93. Optimistic: $2.34


Immix Biopharma Stock Prediction for Sep 2024

An downtrend is forecast for this month with an optimal target price of $1.9279. Pessimistic: $1.80. Optimistic: $2.22


Immix Biopharma Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $1.89956. Pessimistic: $1.80. Optimistic: $2.22


Immix Biopharma Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $1.85169. Pessimistic: $1.59. Optimistic: $1.96


Immix Biopharma Stock Prediction for Dec 2024

An uptrend is forecast for this month with an optimal target price of $1.89835. Pessimistic: $1.63. Optimistic: $2.08



Immix Biopharma (IMMX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 2.11 1.96 2.40 18.07
Feb 2.31 2.06 2.46 16.53
Mar 2.26 2.13 2.57 16.97
Apr 2.40 2.20 2.79 21.15
May 2.57 2.40 2.84 15.74
Jun 2.34 2.08 2.49 16.76
Jul 2.72 2.58 2.95 12.59
Aug 2.92 2.53 3.32 23.79
Sep 2.71 2.28 3.17 28.05
Oct 2.82 2.69 2.99 10.08
Nov 2.55 2.20 2.91 24.44
Dec 2.94 2.71 3.12 13.04

Immix Biopharma (IMMX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 2.87 2.51 3.27 23.24
Feb 2.97 2.63 3.16 16.76
Mar 3.13 2.75 3.65 24.54
Apr 3.31 3.00 3.66 18.21
May 2.90 2.63 3.28 20.03
Jun 3.36 3.18 3.85 17.43
Jul 4.05 3.65 4.57 20.10
Aug 4.91 4.38 5.32 17.63
Sep 5.59 4.68 6.36 26.37
Oct 5.73 5.38 6.15 12.52
Nov 4.72 4.51 5.22 13.66
Dec 4.79 4.16 5.19 19.76

Immix Biopharma (IMMX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 3.85 3.59 4.36 17.62
Feb 3.86 3.24 4.06 20.35
Mar 3.88 3.55 4.13 14.00
Apr 4.15 3.56 4.71 24.44
May 4.78 4.11 5.24 21.64
Jun 5.64 4.96 5.93 16.39
Jul 5.61 4.81 6.22 22.72
Aug 6.19 5.25 7.09 26.00
Sep 6.20 5.63 6.50 13.42
Oct 5.33 4.69 6.13 23.53
Nov 4.86 4.04 5.19 22.19
Dec 4.84 4.03 5.22 22.75

Immix Biopharma (IMMX) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 4.60 4.02 5.05 20.30
Feb 4.53 3.77 4.91 23.05
Mar 4.62 4.29 5.34 19.63
Apr 4.27 3.71 4.84 23.33
May 4.37 4.09 4.76 14.25
Jun 5.29 4.53 5.68 20.15
Jul 5.52 5.06 6.23 18.80
Aug 6.44 6.00 7.18 16.38
Sep 7.60 6.32 8.43 24.99
Oct 6.19 5.31 6.49 18.23
Nov 6.44 5.67 6.87 17.51
Dec 6.16 5.83 6.56 11.04

Immix Biopharma information and performance

Immix Biopharma Address

11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES, CA, US

Market Capitalization: 50 715 000 $

Market capitalization of the Immix Biopharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of IMMX shares in the company outstanding by the market price of one share.

EBITDA: -19 202 520 $

EBITDA of Immix Biopharma is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.93

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: N/A
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: -

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.494

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 26414300

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.